Mogamulizumab‐Associated SAPHO Syndrome: An Unexpected Adverse Event
International Journal of Dermatology · 15.11.2026
DOI: 10.1111/ijd.70782 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 15.11.2026. Verfasst von Elena Porres López und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital "12 de Octubre", Madrid, Spain. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital "12 de Octubre", Madrid, Spain.
ORCID-Profile: Elena Porres López, Paula Hernández Madrid, José Luis Alejo Fernández Baillo, Pablo Ortiz Romero
Zitieren
APA
Porres López, E., Hernández Madrid, P., Alejo Fernández Baillo, J. L., Ortiz Romero, P., & Falkenhain López, D. (2026). Mogamulizumab‐Associated SAPHO Syndrome: An Unexpected Adverse Event. International Journal of Dermatology. https://doi.org/10.1111/ijd.70782
Vancouver
Porres López E, Hernández Madrid P, Alejo Fernández Baillo JL, Ortiz Romero P, Falkenhain López D. Mogamulizumab‐Associated SAPHO Syndrome: An Unexpected Adverse Event. International Journal of Dermatology. 2026. doi:10.1111/ijd.70782
BibTeX
@article{PorresLpez2026,
author = {Porres López, Elena and Hernández Madrid, Paula and Alejo Fernández Baillo, José Luis and Ortiz Romero, Pablo and Falkenhain López, Daniel},
title = {Mogamulizumab‐Associated SAPHO Syndrome: An Unexpected Adverse Event},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70782}
}
EUVIMED